Daniel Baumann
Impact in
-
- Cancer Immunotherapy and Biomarkers
- Cancer Treatment and Pharmacology
-
- Immune cells in cancer
Papers in
- Oncology 7
- Cancer Immunotherapy and Biomarkers 4
- CAR-T cell therapy research 2
- Metal complexes synthesis and properties 2
-
- Immune cells in cancer 3
- Immunotherapy and Immune Responses 3
- Co-authors
- Rienk Offringa (8 shared papers)Petra Högger (2 shared papers)Claus Bachert (2 shared papers)F. Schwemmer (2 shared papers)Roland Zengerle (2 shared papers)O. Strohmeier (2 shared papers)G. Simons (1 shared paper)Felix von Stetten (2 shared papers)
- Journals
- Cancer Research (2 papers)Scientific Reports (2 papers)Nature Communications (1 paper)Calcified Tissue International (1 paper)Journal for ImmunoTherapy of Cancer (1 paper)
- Partner nations
- GermanyBelgiumUnited States
In The Last Decade
Daniel Baumann
22 papers receiving 746 citations
Peers
Comparison fields: 5 of 110
- Oncology 181
- Immunology 95
- Pharmaceutical Science 28
- Molecular Biology 274
- Cancer Research 50
Countries citing papers authored by Daniel Baumann
This map shows the geographic impact of Daniel Baumann's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Daniel Baumann with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Daniel Baumann more than expected).
Fields of papers citing papers by Daniel Baumann
This network shows the impact of papers produced by Daniel Baumann. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Daniel Baumann. The network helps show where Daniel Baumann may publish in the future.
Co-authors
The 25 scholars most cited alongside Daniel Baumann, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 25 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2015 | 119 | |
| 2 | [New drugs. 3]. | 1970 | 85 |
| 3 | [New drugs. 8]. | 1972 | 73 |
| 4 | [New drugs. 5]. | 1971 | 72 |
| 5 | [New drugs. 6]. | 1971 | 69 |
| 6 | [New drugs. 9]. | 1973 | 68 |
| 7 | 2020 | 51 | |
| 8 | 2013 | 48 | |
| 9 | 2021 | 37 | |
| 10 | 2009 | 31 | |
| 11 | 2020 | 23 | |
| 12 | 2020 | 18 | |
| 13 | 2018 | 16 | |
| 14 | A double-antibody sandwich ELISA for the detection of Entamoeba histolytica antigen in stool samples of humans. | 1987 | 15 |
| 15 | 1975 | 14 | |
| 16 | 2020 | 12 | |
| 17 | 1976 | 9 | |
| 18 | 2011 | 8 | |
| 19 | 2015 | 3 | |
| 20 | 1974 | 2 |
About Daniel Baumann
Daniel Baumann is a scholar working on Oncology, Immunology, Organic Chemistry, Molecular Biology and Electronic, Optical and Magnetic Materials, having authored 25 papers that have together received 778 indexed citations. Recurring topics across this work include Cancer Immunotherapy and Biomarkers (4 papers), Organometallic Complex Synthesis and Catalysis (4 papers), Immune cells in cancer (3 papers), Immunotherapy and Immune Responses (3 papers), Magnetism in coordination complexes (3 papers), Biosensors and Analytical Detection (2 papers), CAR-T cell therapy research (2 papers) and Metal complexes synthesis and properties (2 papers). The work is most often cited by research in Oncology (181 citations), Immunology (95 citations), Pharmaceutical Science (28 citations), Molecular Biology (274 citations) and Cancer Research (50 citations). Daniel Baumann has collaborated with scholars based in Germany, Belgium and United States. Frequent co-authors include Rienk Offringa, Petra Högger, Claus Bachert, F. Schwemmer, Roland Zengerle, O. Strohmeier, G. Simons, Felix von Stetten, Fabian Stumpf and Daniel Mark. Their work appears in journals such as Cancer Research, Scientific Reports, Nature Communications, Calcified Tissue International and Journal for ImmunoTherapy of Cancer.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.